[ad_1] Bristol-Myers Squibb Co. BMY, + 0.02% On Friday, a late-stage trial of a small-cell lung cancer treatment did not achieve its primary goal. The pharmaceutical company said that the Phase 3 …
Read More »According to Bristol-Myers, the trial of a treatment for small cell lung cancer has not achieved the main goal
